Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ase Industrial Holding Ltd ADR (NY: ASX )

10.53 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 109
Open 10.53
Bid (Size) 10.30 (2)
Ask (Size) 10.84 (1)
Prev. Close 10.53
Today's Range 10.53 - 10.53
52wk Range 6.830 - 11.68
Shares Outstanding 4,408,018,732
Dividend Yield 5.42%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire

Performance

YTD
+15.97%
+15.97%
1 Month
-5.22%
-5.22%
3 Month
+15.71%
+15.71%
6 Month
+31.46%
+31.46%
1 Year
+48.73%
+48.73%

More News

Read More
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Unlocking ASX Trading Success: WISETECH GLOBAL LIMITED - WTC Stock Analysis & Elliott Wave Technical Forecast
Via Talk Markets
Unlocking ASX Trading Success: ASX Limited
Via Talk Markets
Unlocking ASX Trading Success: REECE LIMITED - REH Stock Analysis & Elliott Wave Technical Forecast
Via Talk Markets
ASE Technology Falls Short Of Revenue Goals, Delivers Mixed Q1 Results
Via Benzinga
ASX Stock Earnings: ASE Tech Holding Co Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
CBA Stock Analysis & Elliott Wave Technical Forecast
Via Talk Markets
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
OTCQX Best 50 Virtual Investor Conference Agenda Announced for April 18th
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Unlocking ASX Trading Success: COCHLEAR LIMITED - COH Stock Analysis & Elliott Wave Technical Forecast
Via Talk Markets
These 10 AI Stocks Have The Best Buy And Hold Valuation Metrics
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE’s VIPack™ Enables Innovational AI Devices Through Advanced Interconnect Technology for Chiplets
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
NeoGames Announces Fourth Quarter and Full Year 2023 Results
From NeoGames SA
Via GlobeNewswire
3 Overlooked Emerging Markets Opportunities: Turkey, Thailand & Taiwan
Via InvestorPlace
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Carnegie Clean Energy to Present at Clean/Renewable Energy Virtual Investor Conference February 22nd
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
5 Semiconductor stocks under $10
Via MarketBeat
Topics Artificial Intelligence Earnings
Exposures Artificial Intelligence Financial
OTC Markets Group Welcomes Tolu Minerals Limited to OTCQX
From OTC Markets
Via GlobeNewswire
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.